An Open Label, Randomized Control Proof of Concept Study to Compare the Effectiveness of Thiriloga Chendhuram (TC) with Annabedhi Chendhuram (ABC; Active Control) in the Treatment of Veluppu Noi (Iron Deficiency Anemia) in Women of Reproductive Age:

This proof-of-concept study addresses the challenges of IDA in women of reproductive age, emphasizing the potential role of Siddha medicine and offering alternatives for managing IDA. This trial also assesses the reticulocyte hemoglobin content (CHr) and percentage of hypochromic cells (% hypo), which offer enhanced sensitivity, specificity, and reliability for diagnosing IDA. The findings will pave the way for future large-scale trials and also contribute to innovative approaches in addressing IDA.

Authors

Institutions

Publication Details

Journal
Advanced Biomedical Research
Published
2025-12-01
DOI
https://doi.org/10.4103/abr.abr_74_24
Primary Topic
Phytochemicals and Medicinal Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Open Label, Randomized Control Proof of Concept Study to Compare the Effectiveness of Thiriloga Chendhuram (TC) with Annabedhi Chendhuram (ABC; Active Control) in the Treatment of Veluppu Noi (Iron Deficiency Anemia) in Women of Reproductive Age:

Rajendra Kumar Arumugam, Siva Annamalai, Shyamala Rajkumar, Archana Arivazhagan et al.
Advanced Biomedical Research
Phytochemicals and Medicinal Plants
article

An Open Label, Randomized Control Proof of Concept Study to Compare the Effectiveness of Thiriloga Chendhuram (TC) with Annabedhi Chendhuram (ABC; Active Control) in the Treatment of Veluppu Noi (Iron Deficiency Anemia) in Women of Reproductive Age:

Rajendra Kumar Arumugam, Siva Annamalai, Shyamala Rajkumar, Archana Arivazhagan, Gayathri Gunalan
article en

Abstract

This proof-of-concept study addresses the challenges of IDA in women of reproductive age, emphasizing the potential role of Siddha medicine and offering alternatives for managing IDA. This trial also assesses the reticulocyte hemoglobin content (CHr) and percentage of hypochromic cells (% hypo), which offer enhanced sensitivity, specificity, and reliability for diagnosing IDA. The findings will pave the way for future large-scale trials and also contribute to innovative approaches in addressing IDA.

Advanced Biomedical ResearchVol. 14(1)
Central Council for Research in Siddha (IN)
Gender equality
Openalex Percentile: Top 23%
Phytochemicals and Medicinal Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.